2161 — Jbm (Healthcare) Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.80bn
- HK$1.79bn
- HK$648.42m
- 89
- 66
- 79
- 93
Annual cashflow statement for Jbm (Healthcare), fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 54 | 41.7 | 30.7 | 76.9 | 165 |
| Depreciation | |||||
| Non-Cash Items | -7.78 | 8.62 | 10.7 | 1.35 | 13.1 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -43.8 | -35.1 | -29.2 | 23.7 | -33.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 38.3 | 58.8 | 60 | 146 | 191 |
| Capital Expenditures | -4.52 | -23 | -7.06 | -8.13 | -10.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 47.9 | -1.49 | -0.493 | 1.35 | 18.5 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 43.4 | -24.5 | -7.55 | -6.78 | 8.31 |
| Financing Cash Flow Items | -44.3 | -13.2 | -7.37 | -8.97 | -9.46 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -59.3 | -13.9 | -76.9 | -56 | -211 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21.8 | 21.6 | -24.5 | 82.4 | -11.5 |